The Claim
Azure I, the N-demethylated metabolite of methylene blue, does not restore mitochondrial membrane potential or increase non-phosphorylating respiration in isolated mouse brain mitochondria, despite being a more potent monoamine oxidase inhibitor, suggesting its therapeutic effects may not involve mitochondrial electron transport bypass.
What the research says
Supports is higher
Support is ahead, but a single strong opposing study can change this.
These are independent scores, not a percentage. Higher-grade studies count more, so a single strong opposing study can outweigh several weaker ones.
A chemical called Azure I, which comes from methylene blue, doesn’t fix the energy power plants in mouse brain cells—even though it’s better at blocking certain brain enzymes. This means it might work in other ways, not by helping cells make energy.
See the scientific wording
Azure I, the N-demethylated metabolite of methylene blue, does not restore mitochondrial membrane potential or increase non-phosphorylating respiration in isolated mouse brain mitochondria, despite being a more potent monoamine oxidase inhibitor, suggesting its therapeutic effects may not involve mitochondrial electron transport bypass.
What the research says
1 studyAzure I, a breakdown product of methylene blue, doesn’t help mitochondria produce energy the way methylene blue does—even though it’s stronger at blocking certain brain enzymes. So its healing effects probably come from something else, not from fixing energy production in cells.
Score breakdown, mechanism chain, raw evidence, ideal studies needed & 1 supporting studies
Not medical advice. For informational purposes only. Always consult a qualified healthcare professional before making health decisions.